Find the investors funding Health Seed rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Singapore-based biotech K2 Therapeutics secures US$50 million seed round; appoints Huang Ying as CEO - The Business Times
K2 Therapeutics is a Singapore-based biotech company focused on developing innovative therapies. The company has recently secured a significant seed funding round to advance its research and development efforts. This funding will support their mission to create impactful solutions in the healthcare sector.
Singapore-based biotech K2 Therapeutics secures US$50 million seed round; appoints Huang Ying as CEO The Business Times
| Oct 27, 2026 | Stryv | $11.5M | Series B | Singapore |
| Oct 21, 2026 | Genie Health | $3.0M | Seed | Singapore |
| Oct 19, 2026 | Blue Whale Energy | $4.0M | Seed | Singapore |
| Oct 08, 2026 | Quantum Startup | $100.0M | — | Singapore |
You just read who funded K2 Therapeutics. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.